• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics from proprietary cannabinoid product platform in a broad range of disease areas. The company operates through the following segments: Commercial, Sativex Research & Development, and Pipeline Research & Development. The Commercial segment distributes and sells the commercial products and promotes Sativex through collaborations with pharmaceutical companies for the currently approved indication of spasticity due to multiple sclerosis. The Sativex Research & Development segment seeks to maximize the potential of Sativex through the development of new indications. The Pipeline Research & Development segment seeks to develop cannabinoid medications other than Sativex, which are using the proprietary cannabinoid technology platform. The company was founded by Geoffrey W. Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.
Market Cap | 6.905 Billion | Shares Outstanding | 31.534 Million | Avg 30-day Volume | 475.571 Thousand |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | |
Price to Revenue | 12.1631 | Debt to Equity | 0.0 | EBITDA | -56.176 Million |
Price to Book Value | 9.234 | Operating Margin | -11.734300000000001 | Enterprise Value | 6.342 Billion |
Current Ratio | 4.485 | EPS Growth | 0 | Quick Ratio | 3.389 |
1 Yr BETA | 0.4796 | 52-week High/Low | 0.0 / | Profit Margin | -12.4929 |
Operating Cash Flow Growth | 75.4926 | Altman Z-Score | 20.3039 | Free Cash Flow to Firm | -110.121 Million |
Please sign in first
none
none
none
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
GUY GEOFFREY W DR EXECUTIVE CHAIRMAN |
|
No longer subject to file | 2021-05-05 | 0 |
|
No longer subject to file | 2021-05-05 | 0 | |
|
No longer subject to file | 2021-05-05 | 0 | |
|
No longer subject to file | 2021-05-05 | 0 | |
CLINE DARREN S U.S. CHIEF COMMERCIAL OFFICER |
|
No longer subject to file | 2021-05-05 | 0 |
|
No longer subject to file | 2021-05-05 | 0 | |
KNAPPERTZ VOLKER CHIEF MEDICAL OFFICER |
|
No longer subject to file | 2021-05-05 | 0 |
SNYDER DOUGLAS B. CHIEF LEGAL OFFICER |
|
No longer subject to file | 2021-05-05 | 0 |
GOVER JUSTIN D. CHIEF EXECUTIVE OFFICER |
|
No longer subject to file | 2021-05-05 | 0 |
|
No longer subject to file | 2021-05-05 | 0 | |
|
No longer subject to file | 2021-05-05 | 0 | |
GIACOBELLO SCOTT M. CHIEF FINANCIAL OFFICER |
|
No longer subject to file | 2021-05-05 | 0 |
TOVEY CHRISTOPHER J. CHIEF OPERATING OFFICER |
|
No longer subject to file | 2021-05-05 | 0 |
GEORGE ADAM D. SECRETARY |
|
No longer subject to file | 2021-01-21 | 0 |
GANGOLLI JULIAN S PRESIDENT, NORTH AMERICA |
|
No longer subject to file | 2019-05-10 | 0 |
|
0 | 2019-03-01 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No current insider transactions |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|---|---|---|---|
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 22:15:02 UTC | -0.4123 | 0.4623 | 900000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 21:45:03 UTC | -0.4123 | 0.4623 | 900000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 21:15:03 UTC | -0.4123 | 0.4623 | 900000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 20:45:03 UTC | -0.4123 | 0.4623 | 900000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 20:15:03 UTC | -0.4123 | 0.4623 | 900000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 19:45:02 UTC | -0.4123 | 0.4623 | 900000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 19:15:03 UTC | -0.4123 | 0.4623 | 900000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 18:45:03 UTC | -0.4123 | 0.4623 | 900000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 18:15:03 UTC | -0.4123 | 0.4623 | 900000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 17:45:03 UTC | -0.4123 | 0.4623 | 900000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 17:15:03 UTC | -0.4123 | 0.4623 | 900000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 16:45:03 UTC | -0.4123 | 0.4623 | 900000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 16:15:03 UTC | -0.4123 | 0.4623 | 900000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 15:45:03 UTC | -0.4123 | 0.4623 | 900000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 15:15:02 UTC | -0.4123 | 0.4623 | 900000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 14:45:04 UTC | -0.4123 | 0.4623 | 900000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 14:15:03 UTC | -0.4123 | 0.4623 | 600000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 13:45:03 UTC | -0.4123 | 0.4623 | 600000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 13:15:03 UTC | -0.4123 | 0.4623 | 600000 |
GW PHARMACEUTICALS -ADR GWPH | 2021-05-05 12:45:02 UTC | -0.4123 | 0.4623 | 600000 |
Holder | Issuer | Net Short Position | Position Date | Origin |
---|